Sihuan Pharmaceutical Holdings Group Ltd. (SEHK: 460)
Health Care · Pharmaceuticals · HK
HK$0.88
+1.74% today · -38.8% 1Y
Sihuan Pharmaceutical Holdings Group Ltd. (SEHK: 460) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.01B.
Over the last twelve months the share price has lost 38.8%, trading between 0.82 and 1.92.
Tweenvest scores Sihuan Pharmaceutical Holdings Group Ltd. across four factors: quality 69/100, value 58/100, growth 5/100, dividend 75/100. Its strongest factor is dividend.
460 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.01B
- Revenue (TTM)
- $374.30M
- P/E
- 39.92
- EPS
- 0.02
- Dividend yield
- 2.56%
- Beta (5Y)
- 0.89
- 52-week high
- HK$1.92
- 52-week low
- HK$0.82
- Avg volume (3M)
- —
- Shares outstanding
- 9.02B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,190.02 | -3.54% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.56 | -0.94% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.39 | -1.96% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.33 | -0.86% |
Figures last refreshed Aug 18, 2026.